Price T Rowe Associates Inc Biolife Solutions Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 16,407 shares of BLFS stock, worth $436,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,407
Previous 15,129
8.45%
Holding current value
$436,426
Previous $281,000
25.27%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BLFS
# of Institutions
180Shares Held
46.1MCall Options Held
11.6KPut Options Held
800-
Casdin Capital, LLC New York, NY8.71MShares$232 Million16.09% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$146 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$88.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$74.1 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$42 Million0.17% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.14B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...